Science Daily: Pharmacology News
JANUARY 31, 2025
Increased use of ventilation and air cleaners, designed to mitigate the spread of viral infections in hospitals, is likely to have unpredictable effects and may cause viral particles to move around more, according to a new study.
BioPharma Drive: Drug Pricing
JANUARY 30, 2025
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Covalent Modifiers
JANUARY 30, 2025
William McCoull, Clare Thomson, Erin Braybrooke, Christina Chan, Nicola Colclough, Miguel A. Corts Gonzlez, Sabina Cosulich, Nichola L. Davies, Nicolas Floch, Ryan Greenwood, David Hargreaves, Peng Huang, Thomas A. Hunt, Tony Johnson, Peter Johnstrm, Jason G. Kettle, Mikhail Kondrashov, Demetrios H. Kostomiris, Songlei Li, Andrew Lister, Scott Martin, Darren McKerrecher, Neville McLean, J.
Drugs.com
JANUARY 31, 2025
FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
JANUARY 28, 2025
The study helps explain why 2023 and early 2024 saw unprecedented ocean temperatures.
BioPharma Drive: Drug Pricing
JANUARY 28, 2025
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
JANUARY 29, 2025
WEDNESDAY, Jan. 29, 2025 -- A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure. The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to.
Science Daily: Pharmacology News
JANUARY 27, 2025
An interdisciplinary team of researchers has projected that if the rate of global CO2 emissions continues to increase and reaches a high emission scenario, sea levels would as a result very likely rise between 0.5 and 1.9 meters by 2100. The high end of this projection's range is 90 centimeters higher than the latest United Nations' global projection of 0.6 to 1.0 meters.
BioPharma Drive: Drug Pricing
JANUARY 31, 2025
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
Chemical Biology and Drug Design
JANUARY 30, 2025
The remarkable therapeutic potential of luteolin against cervical cancer can be ascribed to its profound influence on amino acid and nucleotide metabolism, substantiated by the seamless integration of metabolomics, bioinformatics, and molecular docking techniques in this comprehensive investigation. ABSTRACT The incidence of cervical cancer is high among women globally.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drugs.com
JANUARY 29, 2025
WEDNESDAY, Jan. 29, 2025 -- Hidden hunger -- low levels of essential vitamins or minerals -- is common among people with type 2 diabetes, a new evidence review saysOverall, as many as 45% of type 2 diabetics are suffering multiple deficiencies in.
Science Daily: Pharmacology News
JANUARY 31, 2025
In a comprehensive systematic review and meta-analysis, researchers have taken a deep dive into the effects of cold-water immersion on health and wellbeing. Analyzing data from 11 studies with 3177 participants, researchers found that cold-water immersion may lower stress, improve sleep quality, and boost quality of life.
BioPharma Drive: Drug Pricing
JANUARY 28, 2025
The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ahead of chemotherapy in a variety of tumors.
Chemical Biology and Drug Design
JANUARY 25, 2025
N -substituted-5-([2,5-dihydroxybenzyl]-amino)salicylamides; 1 11 , exhibited invitro anticancer activity, with Compounds 4 , 5 , and 9 being most potent. COMPARE analysis showed polypharmacological multitargeting compounds. Compounds 4 , 5 , 9 11 displayed a remarkable EGFR-TK invitro inhibitory activity, induced apoptosis in NCI-H522 cell line, and showed predicted ADME pharmacokinetic profile.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
JANUARY 28, 2025
TUESDAY, Jan. 28, 2025 -- Kansas health officials are fighting the largest tuberculosis (TB) outbreak in U.S. history, with 67 confirmed cases since new year began.The outbreak includes 60 active cases in Wyandotte County and seven in Johnson.
Science Daily: Pharmacology News
JANUARY 31, 2025
A team of scientists has made the first experimental measurements of laser-induced motions of miniature lightsails in the lab.
BioPharma Drive: Drug Pricing
JANUARY 29, 2025
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, which hasn’t yet proven it can improve outcomes in kidney disease.
Chemical Biology and Drug Design
JANUARY 25, 2025
Coumarin-3-carboxamide analogues were designed, synthesized, and evaluated for pancreatic lipase (PL) inhibition. Among the analogues, 5dh and 5de showed best PL inhibition, with IC 50 values of 9.20 and 11.4M, respectively, compared to Orlistat (IC 50 =0.97M). Analogue 5dh inhibited PL competitively with a K i of 4.504M. ABSTRACT A set of coumarin-3-carboxamide analogues were designed, synthesized, and evaluated for their ability to impede pancreatic lipase (PL) activity.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
JANUARY 27, 2025
MONDAY, Jan. 27, 2025 -- After years of speculation, the CIA has weighed in yet again: A lab leak is now considered the likely origin of the COVID pandemic. However, the agency admits it has "low confidence" in its conclusion and says both a.
Science Daily: Pharmacology News
JANUARY 30, 2025
U of T Scarborough researchers have directly linked population decline in polar bears living in Western Hudson Bay to shrinking sea ice caused by climate change.
BioPharma Drive: Drug Pricing
JANUARY 27, 2025
Taking control of O2 — ushering in the future of cell therapy research.
Chemical Biology and Drug Design
JANUARY 27, 2025
This study investigates the effects and mechanisms of combining Polyphyllin VII (PPVII) with Docetaxel (DTX) in the treatment of prostate cancer (Pca). Experiments were conducted using DTX-sensitive DU-145 cells and DTX-resistant DU145/DTX cells. The results indicate that PPVII significantly enhanced the inhibitory effect of DTX, reduced cell viability, and promoted apoptosis and cell cycle arrest.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
JANUARY 28, 2025
TUESDAY, Jan. 28, 2025 -- Helping kids with obesity drop pounds can have a huge impact on their future health.When these children and teens lose weight, they are less likely to have type 2 diabetes, high blood pressure and elevated cholesterol as.
Science Daily: Pharmacology News
JANUARY 31, 2025
Low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic-associated fatty liver disease, a new study in mice suggests.
BioPharma Drive: Drug Pricing
JANUARY 30, 2025
The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations and financial commitments.
Chemical Biology and Drug Design
JANUARY 30, 2025
New 9H purine derivatives were designed and synthesized, and CDK9 inhibitory activity were evaluated. Compound B5 behaved as a highly selective inhibitors of CDK9. ABSTRACT Cyclin-dependent kinase 9 (CDK9) is considered as an important target in the research of antitumor drugs. Taking the CDK2/9 inhibitor CYC065 as the positive control and an in-house library compound ( 64 ) as the lead compound, four classes of 22 target compounds with 9H purine as the core structure were designed to establish
Drugs.com
JANUARY 29, 2025
WEDNESDAY, Jan. 29, 2025 -- A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread. The strain was discovered at a commercial duck farm in California's Merced.
Science Daily: Pharmacology News
JANUARY 28, 2025
A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse with two male parents -- that lived until adulthood. Their results describe how targeting a particular set of genes involved in reproduction allowed the researchers to overcome previously insurmountable challenges in unisexual reproduction in mammals.
BioPharma Drive: Drug Pricing
JANUARY 30, 2025
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go public.
Chemical Biology and Drug Design
JANUARY 30, 2025
A pyrazolopyrimidine, 2-((4-methoxyphenyl)amino)-7-(pyridin-2-yl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile exhibits TLR7 agonistic activity and stimulates an innate immune response in RAW264.7 macrophages. ABSTRACT Compounds containing pyrazolopyrimidine scaffolds were designed and synthesized as toll-like receptor 7 (TLR7) agonists. Thirty-three compounds, including 22 novel compounds, were prepared, and their structures were identified using nuclear magnetic resonance spectroscopy and mass spec
Drugs.com
JANUARY 31, 2025
FRIDAY, Jan. 31, 2025 -- A rapid blood test could speed treatment for people whove suffered a stroke related to brain bleeding, a new study says.Stroke victims with brain bleeds have nearly seven times higher blood levels of a brain protein called.
Science Daily: Pharmacology News
JANUARY 27, 2025
Archaeologists have uncovered evidence that a house in England is the site of a lost residence of Harold, the last Anglo-Saxon King of England, and shown in the Bayeux Tapestry. By reinterpreting previous excavations and conducting new surveys, the team believe they have located a power center belonging to Harold Godwinson, who was killed in the Battle of Hastings in 1066.
Expert insights. Personalized for you.
299 
Let's personalize your content